
Evidence-based management of bullous pemphigoid.
Publication
, Journal Article
Daniel, BS; Borradori, L; Hall, RP; Murrell, DF
Published in: Dermatol Clin
October 2011
Bullous pemphigoid (BP) is the most common autoimmune subepidermal bullous disease typically affecting the elderly. Although different therapeutic regimens have been proposed, a review of the evidence is needed to aid clinicians in their decision making and management. Systemic therapies such as corticosteroids and adjuvants are effective in BP but are plagued with adverse effects, and potent topical steroids are an alternative treatment. This article reviews the evidence supporting different therapeutic options in the management of BP.
Duke Scholars
Published In
Dermatol Clin
DOI
EISSN
1558-0520
Publication Date
October 2011
Volume
29
Issue
4
Start / End Page
613 / 620
Location
United States
Related Subject Headings
- Randomized Controlled Trials as Topic
- Pemphigoid, Bullous
- Niacinamide
- Methotrexate
- Immunosuppressive Agents
- Immunoglobulins, Intravenous
- Humans
- Evidence-Based Medicine
- Dermatology & Venereal Diseases
- Dermatologic Agents
Citation
APA
Chicago
ICMJE
MLA
NLM
Daniel, B. S., Borradori, L., Hall, R. P., & Murrell, D. F. (2011). Evidence-based management of bullous pemphigoid. Dermatol Clin, 29(4), 613–620. https://doi.org/10.1016/j.det.2011.06.003
Daniel, Benjamin S., Luca Borradori, Russell P. Hall, and Dédée F. Murrell. “Evidence-based management of bullous pemphigoid.” Dermatol Clin 29, no. 4 (October 2011): 613–20. https://doi.org/10.1016/j.det.2011.06.003.
Daniel BS, Borradori L, Hall RP, Murrell DF. Evidence-based management of bullous pemphigoid. Dermatol Clin. 2011 Oct;29(4):613–20.
Daniel, Benjamin S., et al. “Evidence-based management of bullous pemphigoid.” Dermatol Clin, vol. 29, no. 4, Oct. 2011, pp. 613–20. Pubmed, doi:10.1016/j.det.2011.06.003.
Daniel BS, Borradori L, Hall RP, Murrell DF. Evidence-based management of bullous pemphigoid. Dermatol Clin. 2011 Oct;29(4):613–620.

Published In
Dermatol Clin
DOI
EISSN
1558-0520
Publication Date
October 2011
Volume
29
Issue
4
Start / End Page
613 / 620
Location
United States
Related Subject Headings
- Randomized Controlled Trials as Topic
- Pemphigoid, Bullous
- Niacinamide
- Methotrexate
- Immunosuppressive Agents
- Immunoglobulins, Intravenous
- Humans
- Evidence-Based Medicine
- Dermatology & Venereal Diseases
- Dermatologic Agents